MedPath

Femoral Tunnel Position on Conventional MRI After Anterior Cruciate Ligament Reconstruction-Transtibial Technique Versus Transportal Technique

Not Applicable
Completed
Conditions
Anterior Cruciate Ligament Rupture
Registration Number
NCT01513434
Lead Sponsor
National Police Hospital
Brief Summary

The position of the femoral tunnel in anterior cruciate ligament (ACL) reconstruction has been assessed on three dimensional CT (3D-CT) scan or in cadaveric study. However, these methods have some issues; 3D-CT scan has a concern on radiation exposure and cadaveric study is not easily available nor an in vivo test. The purpose of this study is to compare the position of the femoral tunnel aperture on conventional MRI and the outcomes after single bundle ACL reconstruction using free tendon Achilles allograft between transportal technique and transtibial technique in active young men.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
64
Inclusion Criteria
  • diagnosis of anterior cruciate ligament rupture
Exclusion Criteria
  • female
  • over 45 years old
  • the subjects who had ACL reconstruction with graft other than Achilles allograft
  • the subjects who had concomitant other ligament injuries on the same knee needing surgical treatment
  • revision ACL reconstruction
  • double bundle ACL reconstruction
  • concomitant full thickness cartilage injury needing cartilage repairing surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Lysholm scoreat least two years after surgery

Lysholm score was superior in transportal technique to transtibial technique.

Position of femoral tunnel aperturewithin one week after surgery

The position of the femoral tunnel aperture with transportal technique was more posterior than that of transtibial technique.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Police Hospital

🇰🇷

Seoul, Korea, Republic of

National Police Hospital
🇰🇷Seoul, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.